Jones Trading Upgrades Editas Medicine to Buy, Announces $8 Price Target
Benzinga Newsdesk 7 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Jones Trading analyst Soumit Roy upgrades Editas Medicine (NASDAQ:EDIT) from Hold to Buy and announces $8 price target.
Jones Trading analyst Soumit Roy upgrades Editas Medicine (NASDAQ:EDIT) from Hold to Buy and announces $8 price target.